STOCK TITAN

Director at Medtronic (NYSE: MDT) receives 1,803 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lee Joon Sup reported acquisition or exercise transactions in this Form 4 filing.

Medtronic plc reported that director Lee Joon Sup received an equity award of 1,803 ordinary shares in the form of restricted stock units. These units were granted at no cash cost and will vest on the one-year anniversary of the award date. Following this grant, Lee directly holds 1,803 ordinary shares.

Positive

  • None.

Negative

  • None.
Insider Lee Joon Sup
Role null
Type Security Shares Price Value
Grant/Award Ordinary Shares 1,803 $0.00 --
Holdings After Transaction: Ordinary Shares — 1,803 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Equity award size 1,803 shares Restricted stock unit grant to director Lee Joon Sup
Grant price per share $0.00 per share Recorded transaction price for RSU award
Shares held after transaction 1,803 shares Total direct Medtronic ordinary shares after grant
restricted stock units financial
"Represents an award of restricted stock units that vest on the one-year"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
grant, award, or other acquisition financial
"transaction code description is Grant, award, or other acquisition"
Ordinary Shares financial
"security_title is Ordinary Shares for this transaction"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lee Joon Sup

(Last)(First)(Middle)
C/O MEDTRONIC
710 MEDTRONIC PARKWAY

(Street)
MINNEAPOLIS MINNESOTA 55432

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares04/27/2026A1,803(1)A$01,803D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents an award of restricted stock units that vest on the one-year anniversary of the award date.
Remarks:
/s/ Patricia Walesiewicz, attorney-in-fact04/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Medtronic (MDT) disclose for Lee Joon Sup?

Medtronic disclosed that director Lee Joon Sup received an equity grant of 1,803 ordinary shares in the form of restricted stock units. The award was recorded at a price of $0.00 per share, reflecting compensation rather than an open-market purchase, and increased his direct holdings to 1,803 shares.

Was Lee Joon Sup’s Medtronic (MDT) share award an open-market purchase?

No, Lee Joon Sup’s 1,803-share award was classified as a grant or award acquisition, not an open-market purchase. The transaction price was recorded as $0.00 per share, which indicates equity compensation provided by Medtronic instead of shares bought in the public market.

How many Medtronic (MDT) shares does Lee Joon Sup hold after the grant?

After receiving the restricted stock unit award, Lee Joon Sup directly holds 1,803 Medtronic ordinary shares. The entire reported position comes from this single equity grant, which was characterized as a grant, award, or other acquisition rather than a market trade or derivative exercise.

When do Lee Joon Sup’s Medtronic restricted stock units vest?

The 1,803 restricted stock units awarded to Lee Joon Sup vest on the one-year anniversary of the award date. Vesting means the units convert into owned shares over time, aligning director compensation with company performance and encouraging longer-term alignment with Medtronic shareholders.

What does the transaction code for Lee Joon Sup’s Medtronic award mean?

The transaction used code “A,” described as a grant, award, or other acquisition. This indicates Medtronic granted 1,803 restricted stock units to Lee Joon Sup as compensation, rather than him buying or selling shares in the open market or exercising stock options.